Cargando…

The role of death receptor 3 in the biological behavior of hepatocellular carcinoma cells

Death receptor 3 (DR3) belongs to the tumor necrosis factor (TNF) receptor superfamily, primarily found in lymphoid tissues. Reports have determined that DR3 may also be distributed in numerous types of tumors. Therefore, it is thought that DR3 may have an important role in the process of tumorigene...

Descripción completa

Detalles Bibliográficos
Autores principales:	ZHANG, YOU CHENG, GUO, LIU QING, CHEN, XIAO, WANG, GEN NIAN, NI, RI, WANG, MAN CAI, WEI, FENG XIAN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262488/ https://www.ncbi.nlm.nih.gov/pubmed/25370568 http://dx.doi.org/10.3892/mmr.2014.2858

Ejemplares similares

Elective Splenectomy Combined with Modified Hassab's or Sugiura Procedure for Portal Hypertension in Decompensated Cirrhosis
por: Zhang, Ya-wu, et al.
Publicado: (2019)

MRI Features of Hepatocellular Carcinoma Related to Biologic Behavior
por: Cho, Eun-Suk, et al.
Publicado: (2015)

PRISMA—Efficacy and Safety of Vedolizumab for Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Wang, Man Cai, et al.
Publicado: (2014)

Erythropoietin promoted the proliferation of hepatocellular carcinoma through hypoxia induced translocation of its specific receptor
por: Miao, Shuo, et al.
Publicado: (2017)

PRISMA—efficacy and safety of lixisenatide for type 2 diabetes mellitus: A meta-analysis of randomized controlled trials
por: Wei, Zhen-gang, et al.
Publicado: (2018)

Analyzing molecular typing and clinical application of immunogenic cell death-related genes in hepatocellular carcinoma
por: Lin, Cai-Feng, et al.
Publicado: (2023)

Effects and related mechanisms of serotonin on malignant biological behavior of hepatocellular carcinoma via regulation of Yap
por: Liu, Sushun, et al.
Publicado: (2017)

Norcantharidin alone or in combination with crizotinib induces autophagic cell death in hepatocellular carcinoma by repressing c-Met-mTOR signaling
por: Sun, Chao-Yue, et al.
Publicado: (2017)

Up-regulation of chemokine receptor CCR4 is associated with Human Hepatocellular Carcinoma malignant behavior
por: Cheng, Xi, et al.
Publicado: (2017)

miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a
por: Cao, Man-Qing, et al.
Publicado: (2018)

Clinical outcomes of lenvatinib plus transarterial chemoembolization with or without programmed death receptor-1 inhibitors in unresectable hepatocellular carcinoma
por: Wang, Yan-Yu, et al.
Publicado: (2023)

Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a
por: Cao, Man-Qing, et al.
Publicado: (2018)

Lenvatinib Induces Immunogenic Cell Death and Triggers Toll-Like Receptor-3/4 Ligands in Hepatocellular Carcinoma
por: Zhou, Cheng, et al.
Publicado: (2023)

Mechanism Research and Application for Ginsenosides in the Treatment of Hepatocellular Carcinoma
por: Zhou, Nian, et al.
Publicado: (2023)

Blood exosomal micro ribonucleic acid profiling reveals the complexity of hepatocellular carcinoma and identifies potential biomarkers for differential diagnosis
por: Sheng, Lang-Qing, et al.
Publicado: (2020)

The Expression of Estrogen Receptors in Hepatocellular Carcinoma in Korean Patients
por: Wang, Ai Guo, et al.
Publicado: (2006)

GGPPS1 predicts the biological character of hepatocellular carcinoma in patients with cirrhosis
por: Yu, De-cai, et al.
Publicado: (2014)

Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma
por: HOU, SI-CONG, et al.
Publicado: (2013)

MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2
por: Ma, De-Ning, et al.
Publicado: (2016)

Vincosamide Has a Function for Inhibiting Malignant Behaviors of Hepatocellular Carcinoma Cells
por: Zhu, Ming Yue, et al.
Publicado: (2022)

Corilagin induces the apoptosis of hepatocellular carcinoma cells through the mitochondrial apoptotic and death receptor pathways
por: Deng, Yuan, et al.
Publicado: (2018)

Expression and biological significance of c-FLIP in human hepatocellular carcinomas
por: Du, Xilin, et al.
Publicado: (2009)

PFKFB3 blockade inhibits hepatocellular carcinoma growth by impairing DNA repair through AKT
por: Shi, Wen-Kai, et al.
Publicado: (2018)

Emodin Induced SREBP1-Dependent and SREBP1-Independent Apoptosis in Hepatocellular Carcinoma Cells
por: Yang, Nian, et al.
Publicado: (2019)

Prognostic value and immune landscapes of immunogenic cell death-related lncRNAs in hepatocellular carcinoma
por: Chen, Wanying, et al.
Publicado: (2023)

Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death
por: Li, Sainan, et al.
Publicado: (2017)

Hepatocellular Carcinoma with Portal Vein Tumor Thrombus versus Hepatocellular Carcinoma with Biliary Tumor Thrombus: Better or Worse Prognoses? [Letter]
por: Feng, Jin-Kai, et al.
Publicado: (2021)

Progress of MRI Radiomics in Hepatocellular Carcinoma
por: Gong, Xue-Qin, et al.
Publicado: (2021)

Identification of Biological Targets of Therapeutic Intervention for Hepatocellular Carcinoma by Integrated Bioinformatical Analysis
por: Hu, Wei Qi, et al.
Publicado: (2018)

Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma
por: Tseng, Hsiang-chi, et al.
Publicado: (2020)

Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection
por: Wang, Jia-Xing, et al.
Publicado: (2014)

Dahuang Zhechong Pill Combined with Doxorubicin Induces Cell Death through Regulating Energy Metabolism in Human Hepatocellular Carcinoma Cells
por: Wu, Li, et al.
Publicado: (2017)

The clinical significance of lipopolysaccharide binding protein in hepatocellular carcinoma
por: Cai, Quan-Yu, et al.
Publicado: (2020)

Programmed cell death‐ligand 1 expression in hepatocellular carcinoma and its correlation with clinicopathological characteristics
por: Mou, Haibo, et al.
Publicado: (2021)

Cell Death in Hepatocellular Carcinoma: Pathogenesis and Therapeutic Opportunities
por: García-Pras, Ester, et al.
Publicado: (2021)

Hepatocellular carcinoma treated with anti-epidermal growth factor receptor antibody nimotuzumab: A case report
por: Song, Peng, et al.
Publicado: (2017)

The Expression of CLDN6 in Hepatocellular Carcinoma Tissue and the Effects of CLDN6 on Biological Phenotypes of Hepatocellular Carcinoma Cells
por: Lu, Yan, et al.
Publicado: (2021)

Suberoylanilide hydroxamic acid upregulates reticulophagy receptor expression and promotes cell death in hepatocellular carcinoma cells
por: Li, Jia-Yao, et al.
Publicado: (2023)

Hepatocellular carcinoma successfully treated with ALPPS and apatinib: A case report
por: Liu, Ling, et al.
Publicado: (2019)

Hepatocellular carcinoma: a systems biology perspective
por: D'Alessandro, Lorenza A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_k4a643a92d7e86r0f1l873dtdm